Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05219435
Title Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer (VEXILLUM)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Spanish Oncology Genito-Urinary Group
Indications

transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma

urethra transitional cell carcinoma

Therapies

Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.